The Center for Disease Control has received numerous reports of an eosinophilia-myalgia syndrome related to products containing Ltryptophan. The case is reported of eosinophilia-myalgia syndrome and polyneuropathy associated with myeloperoxidase specific antineutrophil cytoplasmic antibody. Accepted for publication 6 October 1990 Case report A 61 year old woman presented in November 1989 with diffuse myalgias, fatigue, and a diffuse, pruritic, maculopapular rash, followed by shortness of breath. There was no history of ingestion of raw meats, recent travel, or contact with ill persons. Her only drug at the time of onset of symptoms was L-tryptophan, 1000 mg (unknown manufacturer) at bedtime for insomnia, which she had been taking for four years. There were no known allergies.
Accepted for publication 6 October 1990 Case report A 61 year old woman presented in November 1989 with diffuse myalgias, fatigue, and a diffuse, pruritic, maculopapular rash, followed by shortness of breath. There was no history of ingestion of raw meats, recent travel, or contact with ill persons. Her only drug at the time of onset of symptoms was L-tryptophan, 1000 mg (unknown manufacturer) at bedtime for insomnia, which she had been taking for four years. There were no known allergies.
On initial examination she was afebrile. There was diffuse muscular tenderness without weakness. Bibasilar rales were noted. Electrocardiogram monitoring showed episodes of paroxysmal atrial tachycardia. Chest radiography showed mild congestive heart failure.
The leucocyte count was 130x 109/l; haemoglobin 123 g/l; packed cell volume 0-37; and platelet count 272x 109/1. The Letters to the editor Corrected serum calcium and full blood count remained normal. A drug induced central nervous system toxicity syndrome was diagnosed by a psychiatrist, and thioridazine reduced the frequency and disturbing effect of the hallucinations. A brain computed tomographic scan was normal.
Studies of patients with Paget's disease treated with pamidronate have consistently shown a transient fall in serum calcium and phosphate, which are seldom of clinical significance and are associated with a decline in urinary calcium excretion and an increase in plasma parathyroid hormone levels.6 Transient haematological changes and fevers have also been reported4 after both oral and IV pamidronate, possibly mediated through direct or indirect effects on mononuclear phagocytes, resulting in the activation of cytokines.3 The mechanism underlying hallucinations in this patient is unknown but is considered unlikely to be due to alterations in serum calcium concentrations.
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